New CRO in Hong Kong to feed China

By Kirsty Barnes

- Last updated on GMT

Related tags: Contract research organization, People's republic of china, China

A new contract research organization (CRO) has opened in Hong Kong
and will be the only clinical trial site outside of China with the
approval of China's State Food and Drug Administration (SFDA) to
run oncology trials.

The new CRO, Bridgetech Medical Technologies Research (BMTR) is part of a new venture between US firm Bridgetech Holdings International and the Chinese University of Hong Kong. Playing a part in the decision to open a CRO in the region was the fact that Hong Kong plays a strategically important role in China's healthcare development, according to Pro-vice-chancellor of the Chinese University Kenneth Young. In addition to running clinical trials the site will also help facilitate regulatory approval from the Chinese regulatory authorities, as well as the US Food and Drug Administration (FDA). The life science market in China is one of the fastest growing markets in the world and demand for contract services continues to escalate as the domestic pharma market continues to mature and many of the world's top pharma companies also begin to set up low-cost manufacturing operations in and around the country. Asia, led by China, has the largest pool of patients with cancer, cardiovascular and infectious diseases - therapeutic areas that are now accounting for 70 per cent of all new drugs.

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars